Targeting the Gut Microbiome for Inflammation and Pain Management in Orthopedic Conditions

Area of Science:

• Orthopedics
• Microbiome research
• Inflammation and immunology

Background:

• The gut microbiome influences systemic inflammation and pain.
• Nonsteroidal anti-inflammatory drugs (NSAIDs) and opioids have adverse effects.
• Orthopedic conditions often involve significant inflammation and pain.

Purpose of the Study:

• To review human trials on gut microbiome alterations for orthopedic pain and inflammation.
• To explore alternatives to NSAIDs and opioids for managing orthopedic conditions.
• To provide evidence for individualized supplementation strategies.

Main Methods:

• Systematic review of human clinical trials.
• Focus on probiotics, prebiotics, synbiotics, and anti-inflammatory foods/spices.
• Analysis of studies targeting osteoarthritis, rheumatoid arthritis, fractures/osteoporosis, and chemotherapy-induced bone pain.

Main Results:

• Gut microbiome modulation shows potential in reducing pain and inflammatory markers.
• Probiotics, prebiotics, and synbiotics can impact orthopedic conditions.
• Dietary anti-inflammatory agents may offer therapeutic benefits.

Conclusions:

• Gut microbiome interventions represent a promising, evidence-based strategy for orthopedic pain and inflammation.
• These strategies can minimize reliance on NSAIDs and opioids.
• Individualized approaches to gut microbiome modulation warrant further investigation.